MAP2K7 and acute myeloid leukemia: Indeed, L-CFU assays enrich for more immature AML progenitor cells compared to liquid culture conditions [51], suggesting a reduced sensitivity to MEK inhibitors of progenitor compared to mature RAS+ cells.